Na+/H+ exchange in hypertension and in diabetes mellitus - facts and hypotheses

Basic Research in Cardiology

Volumn 91, Issue 3, 1996, Pages 179-190

  Siffert, W ^a   Dusing R ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Diabetes; G proteins; Hypertension; Hypertrophy; Nephropathy

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROTON; SODIUM ION;

ARTERY; ARTICLE; CELL IMMORTALIZATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ESSENTIAL HYPERTENSION; GENETIC REGULATION; HYPERTENSION; LYMPHOBLAST; PROTON SODIUM EXCHANGE; THROMBOCYTE AGGREGATION; VASOCONSTRICTION;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; DIABETIC NEPHROPATHIES; GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; SODIUM; SODIUM-HYDROGEN ANTIPORTER;

EID: 0030006320     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00788904     Document Type: Article

References (99)

1. Aalkjaer C, Eiskjaer H, Mulvany MJ, Jespersen B, Kjaer T, Sorensen SS, Pedersen EB (1989) Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 7: 305-310
2. Abrass CK (1995) Diabetic nephropathy. Mechanisms of mesangial matrix expansion. West J Med 162: 318-321
3. Aronow WS, Kronzon I, Schoenfeld MR (1995) Left ventricular hypertrophy is more prevalent in patients with systemic hypertension with extracranial carotid arterial disease than in patients with systemic hypertension without extracranial carotid arterial disease. Am J Cardiol 76: 192-193
4. + exchanger. Annu Rev Physiol 47: 545-560
5. Barbe P, Salles J-P, Barthe P, Louvet J-P, Chap H (1992) Increased platelet sodium-proton exchange rates in insulin-dependent (type 1) diabetic patients with nephropathy and hypertension. Mol Cell Biochem 109: 167-172
6. Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS (1992) Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Int 41: 723-730
7. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites. J Biol Chem 269: 13703-13709
8. + exchangers. J Exp Biol 196: 337-345
9. Bodmer CW, Schaper NC, Janssen M, De Leeuw PW, Williams G (1995) Selective enhancement of alpha 2-adrenoceptor-mediated vasoconstriction in insulin-dependent diabetic patients with microalbuminuria. Clin Sci Colch 88: 421-426
10. Bogoyevitch MA, Clerk A, Sugden PH (1995) Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular myocytes. Biochem J 309: 437-443
11. Busch S, Burckhardt B-C, Siffert W (1995) Expression of the human sodium-proton exchanger NHE-1 in Xenopus laevis oocytes enhances sodium-proton exchange activity and establishes sodium-lithium countertransport. Pflügers Arch 429: 859-869
12. + exchanges of human red cells. Methods Enzymol 173: 176-191
13. Chao W, Olson MS (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292: 617-629
14. Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269: 32023-32026
15. Conklin BR, Bourne HR (1993) Structural elements of Gα subunits that interact with Gβgamma, receptors, and effectors. Cell 73: 631-641
16. + antiporter (NHE1). Cell Physiol Biochem 2: 138-149
17. Counillon L, Pouysségur J (1995) Structure-function studies and molecular regulation of the growth factor activatable sodium-hydrogen exchanger (NHE-1). Cardiovasc Res 29: 147-154
18. + antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Mol Pharmacol 44: 1041-1045
19. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 42: 1184-1190
20. + exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy. Diabetes 44: 382-388
21. De la Sierra A, Coca A, Paré JC, Sánchez M, Valls V, Urbano-Márquez A (1993) Erythrocyte ion fluxes in essential hypertensive patients with left ventricular hypertrophy. Circulation 88: 1628-1633
22. DeVivo M, Iyengar R (1994) G protein pathways: signal processing by effectors. Mol Cell Endocrinol 100: 65-70
23. Doria A, Fioretto P, Avogaro A, Carraro A, Morocutti A, Trevisan R, Frigato F, Crepaldi G, Viberti G, Nosadini R (1991) Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol Endocrinol Metab 261: E684-E691
24. + antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy. Clin Investig 71: 119-125
25. Earle K, Walker J, Hill C, Viberti G (1992) Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326: 673-677
26. Epstein M, Sowers JR (1992) Diabetes mellitus and hypertension. Hypertension 19: 403-418
27. + antiport in rabbit erythrocytes: two distinct transport systems. J Membrane Biol 120: 41-49
28. + antiporter gene transfected into antiporter-deficient mouse L cells. Proc Natl Acad Sci USA 83: 9388-9392
29. Friedman GD, Selby JV Quesenberry Jr CP (1990) The leukocyte count: A predictor of hypertension. J Clin Epidemiol 43: 907-911
30. Gillum RF, Mussolino ME (1994) White blood cell count and hypertension incidence. The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 47: 911-919
31. + antiport: activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest 24: 529-539
32. Göbel BO, Schulte-Göbel A, Weisser B, Glänzer K, Vetter H, Düsing R (1991) Arterial blood pressure. Correlation with erythrocyte count, hematocrit, and hemoglobin concentration. Am J Hypertens 4: 14-19
33. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim Biophys Acta 988: 73-97
34. Gudermann T, Nürnberg B, Schultz G (1995) Receptors and G proteins as primary components of transmembrane signal transduction. Part 1. G-protein-coupled receptors: structure and function. J Mol Med 73: 51-63
35. Hansen HS, Nielsen JR, Hyldebrandt N, Froberg K (1992) Blood pressure and cardiac structure in children with a parental history of hypertension: The Odense Schoolchild Study. J Hypertens 10: 677-682
36. Hostetter TH (1994) Mechanisms of diabetic nephropathy. Am J Kidney Dis 23: 188-192
37. Hostetter TH (1995) Progression of renal disease and renal hypertrophy. Annu Rev Physiol 57: 263-278
38. Inglese J, Koch WJ, Touhara K, Lefkowitz RJ (1995) Gβγ interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem Sci 20: 151-156
39. + exchange. Hypertension 9: 7-12
40. 2+ and protein kinase C. J Biol Chem 265: 21068-21074
41. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC, Rand LI (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140-145
42. +-proton exchanger. Circ Res 76: 148-153
43. Larkins RG, Dunlop ME (1992) The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35: 499-504
44. Lee T-S, Saltsman KA, Ohashi H, King GL (1989) Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86: 5141-5145
45. + exchangers stably expressed in a fibroblast cell line. J Biol Chem 268: 25527-25535
46. Lopes de Faria JB, Friedman R, Tariq T, Viberti G (1992) Prevalence of raised sodium-lithium countertransport activity in type 1 diabetic patients. Kidney Int 41: 877-882
47. βγ subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J Biol Chem 270: 16495-16498
48. Malarkey K, Belham CM, Paul A, Graham A, McLees A, Scott PH, Plevin R (1995) The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J 309: 361-375
49. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti G (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 145-150
50. Moolenaar WH (1995) Lysophosphatidic acid signalling. Curr Opin Cell Biol 7: 203-210
51. Moolenaar WH (1995) Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270: 12949-12952
52. + exchange of rabbit red cells: evidence for a common pathway. J Membrane Biol 118: 193-214
53. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685
54. + antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 93: 2750-2757
55. + antiport in essential hypertension. J Hypertens 8: 533-537
56. + antiport in type 1 (insulin-dependent) diabetic subjects with albuminuria. Diabetologia 33: 278-284
57. + antiport acitivity in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 33: 371-377
58. + exchanger antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension 25: 971-977
59. + exchanger isoforms. Am J Physiol Cell Physiol 268: C283-C296
60. Nürnberg B, Gudermann T, Schultz G (1995) Receptors and G proteins as primary components of transmembrane signal transduction. Part 2. G proteins: structure and function. J Mol Med 73: 123-132
61. Offermanns S, Schultz G (1994) Complex information processing by the transmembrane signaling system involving G proteins. Naunyn Schmiedebergs Arch Pharmacol 350: 329-338
62. Olsen F, Hilden M, Ibsen H (1973) Raised levels of immunoglobulins in serum of hypertensive patients. Acta path microbiol scand 81: 775-778
63. Philipp T, Distler A, Cordes U (1978) Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet: 959-963
64. + exchanger in essential hypertension. Kidney Int 45: 1037-1043
65. + exchange decreases the affinity of sodium sites. Kidney Int 46: 365-375
66. Post WS, Larson MG, Levy D (1994) Impact of left ventricular structure on the incidence of hypertension: The Framingham Heart Study. Circulation 90: 179-185
67. + exchanger isoforms. Renal Physiol Biochem 17: 190-193
68. + antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81: 4833-4837
69. + exchanger activity and NHE-1 mRNA levels in human lymphocytes during metabolic acidosis. Am J Physiol Cell Physiol 266: C480-C488
70. Reaven GM (1993) Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 44: 121-131
71. Reaven GM (1994) Syndrome X: 6 years later. J Intern Med 236 Suppl. 736: 13-22
72. + exchange in human lymphocytes and platelets in chronic and sub-acute metabolic acidosis. J Clin Invest 92: 858-865
73. Ritz E, Nowicki M, Fliser D, Hörner D, Klimm H-P (1994) Proteinuria and hypertension. Kidney Int 46 Suppl. 47: S76-S80
74. Rosskopf D, Düsing R, Siffert W (1993) Membrane sodium-proton exchange and primary hypertension. Hypertension 21: 607-617
75. Rosskopf D, Frömter E, Siffert W (1993) Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients-a cell culture model for human hypertension. J Clin Invest 92: 2553-2559
76. Rosskopf D, Hartung K, Hense J, Siffert W (1995) Enhanced immunoglobulin formation of immortalized B cells from hypertensive patients. Hypertension 26: 432-435
77. + exchange in human B lymphoblasts without influencing proliferation. Cell Physiol Biochem 5: 269-275
78. Rosskopf D, Schröder K-J, Siffert W (1995) Role of sodium-hydrogen exchange in the proliferation of immortalised lymphoblasts from patients with essential hypertension and normotensive subjects. Cardiovasc Res 29: 254-259
79. Safar ME, Simon AC, Levenson JA (1984) Structural changes of large arteries in sustained essential hypertension. Hypertension 6: III-117-III-121
80. + antiporter. Cell 56: 271-280
81. + exchange in patients with diabetic nephropathy and essential hypertension: Therapeutic implications. Ren Fail 15: 331-338
82. + exchanger isoform-1 abundance in skin fibroblasts of type I diabetic patients with nephropathy. Metabolism 44: 791-795
83. Siffert W, Düsing R (1995) Sodium-proton exchange and primary hypertension - an update. Hypertension 26: 649-655
84. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH (1995) Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 96: 759-766
85. Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K (1993) Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 6 Suppl. 260S-270S
86. Strazzullo P, De Simone G, Celentano A, Iacone R, Ragone E, Pagano E, Tammaro P, Canessa M (1991) Sodium-hydrogen exchange and cardiac hypertrophy in patients with primary hypertension. J Hypertens 9 Suppl. 6: S306-S307
87. Suryaprabha P, Padma T, Rao UB (1984) Increased serum IgG levels in essential hypertension. Immunol Lett 8: 143-145
88. + exchange increases after an oral glucose challenge. Circ Res 77: 1024-1029
89. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
90. 2+ concentrations in essential hypertension. Hypertension 22: 853-862
91. + antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41: 1239-1246
92. + exchanger gene family - initial structure/function studies. J Am Soc Nephrol 4: 969-975
93. 2+ regulation-defective. J Biol Chem 269: 13710-13715
94. + exchanger isoform 1 (NHE1). Evidence for an additional mechanism not requiring direct phosphorylation. J Biol Chem 269: 5583-5588
95. +-sensing". Proc Natl Acad Sci USA 89: 2424-2428
96. Wieland T, Liedel K, Kaldenberg-Stasch S, Meyer zu Heringdorf D, Schmidt M, Jakobs KH (1995) Analysis of receptor-G protein interactions in permeabilized cells. Naunyn-Schmiedeberg's Arch Pharmacol 351: 329-336
97. + antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase C. J Clin Invest 93: 2623-2631
98. Williams B, Schrier RW (1993) Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92: 2889-2896
99. + exchanger gene family: structure and function studies. Am J Physiol Gastrointest Liver Physiol 269: G1-G11